Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 172.37 Delayed Data As of Sep 25 |  0.00 / 0.00%Today’s Change | 21.83 Today|||52-Week Range 172.46 | +353.72% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Soni Manmeet Singh |  Sale | 7/28/2023 | 75,000 | $164.62 | $12.3M | -- |
Bir Dawn Carter Chief Commercial Officer | Sale | 7/28/2023 | 40,000 | $164.54 | $6.6M | -- |
Bir Dawn Carter Chief Commercial Officer | Sale | 3/06/2023 | 40,134 | $89.30 | $3.6M | -- |
Bir Dawn Carter Chief Commercial Officer | Sale | 3/07/2023 | 36,049 | $85.08 | $3.1M | -- |
Meyer Colin Chief Innovation Officer | Sale | 3/02/2023 | 34,794 | $86.49 | $3.0M | -- |
Soni Manmeet Singh | Sale | 6/13/2023 | 25,530 | $104.09 | $2.7M | -- |
Meyer Colin Chief Innovation Officer | Sale | 3/02/2023 | 22,752 | $85.23 | $1.9M | -- |
Meyer Colin Chief Innovation Officer | Sale | 3/02/2023 | 19,099 | $87.55 | $1.7M | -- |
Soni Manmeet Singh | Sale | 6/13/2023 | 16,163 | $101.98 | $1.6M | -- |
Khan Samina /quark/ Chief Medical Officer & Senior Vice President | Sale | 3/02/2023 | 18,956 | $85.02 | $1.6M | -- |
Page of 16